SARS-CoV-2-IN-32 [CAS 96068-42-7]

SARS-CoV-2-IN-32 (compound 3g) is a COVID-19 inhibitor. SARS-CoV-2-IN-32 shows anti-proliferative activity against cancer cells. SARS-CoV-2-IN-32 exhibits comparatively high binding affinity (-8.8 Kcal/mole) to COVID-19 main protease (Mpro) (PDB ID: 6LU7) . SARS-CoV-2-IN-32 can be used in studies of cancer and COVID-19[1].

[96068-42-7]

C27H23N5O4

481.5

[O-][N+](C1=CC=C(C(C2=C(N(C3=CC=CC=C3)N=C2C)O)C4=C(N(C5=CC=CC=C5)N=C4C)O)C=C1)=O

SARS-CoV

10 mM in DMSO

Room temperature